• Title/Summary/Keyword: 치료 권고안

Search Result 43, Processing Time 0.022 seconds

Palliative Sedation for Terminal Cancer Patient (말기 암 환자에서 완화적 진정 증례 토론)

  • Kim, Do-Yeun
    • Journal of Hospice and Palliative Care
    • /
    • v.11 no.2
    • /
    • pp.106-110
    • /
    • 2008
  • Palliative sedation has been used in patients who undergo intractable suffering at the end of life. Its implementation, however, may be complicated due to resistance of clinicians and barrier of bioethical issues. Here, we present 50-year-old man with stomach cancer and multiple bone metastasis who was treated with palliative chemotherapy and radiotherapy. He suffered from refractory pain on the whole body even after standard analgesics and multidisplinary effort to relieve. Upon shared decision for sedation, he was given midazolam until discharge. Literature reviews reveal cases similar to the present case.

  • PDF

The Korean Practice Parameter for the Treatment of Pervasive Developmental Disorders : Clinical Manifestation, Epidemiology, Course, Causes, and Comorbidity (전반적 발달장애의 한국형 치료 권고안 : 임상양상, 역학, 경과, 원인, 동반질환)

  • Yoo, Han-Ik;Cho, In-Hee;Yoo, Hee-Jeong;Koo, Young-Jin;Chung, Un-Sun;Ahn, Joung-Sook;Ahn, Dong-Hyun;Son, Jung-Woo
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.18 no.2
    • /
    • pp.88-96
    • /
    • 2007
  • Pervasive developmental disorders are characterized by lifelong impairments in fundamental social and/or communication skills and by the presence of seemingly purposeless and repetitive behaviors, interests, or activities. A number of possible biological etiologies, including genetic, structural and functional brain abnormalities, have been identified in patients with pervasive developmental disorders. In addition, clinicians should take the possibility of comorbid psychiatric conditions into consideration when making the differential diagnosis of pervasive developmental disorders.

  • PDF

The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (IV) - Non-Pharmacologic Treatment - (주의력결핍 과잉행동장애 한국형 치료 권고안(IV) - 비약물적 치료 -)

  • Shin, Yun Mi;Kim, Eui-Jung;Kim, Yunsin;Bhang, Soo Young;Lee, Eunha;Lee, Cheol-Soon;Chang, Hyoung Yoon;Hong, Minha;Shin, Dongwon
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.28 no.2
    • /
    • pp.84-95
    • /
    • 2017
  • Attention-deficit hyperactivity disorder (ADHD) is a neuropsychiatric disorder that begins in early childhood and can persist throughout adulthood. ADHD causes difficulties in various area of life, such as academic achievement, peer relationships, family functioning, employment and marriage. Although ADHD is known to respond well to medication, such treatment is more effective when combined with psychosocial (non-pharmacologic) therapy in terms of alleviating the core symptoms and improving appropriate functions. Psychosocial treatment interventions are divided into psychoeducation, behavioral parent training, school intervention, cognitive behavior therapy, social skill training, parent-child interaction therapy, play therapy, other treatments (coaching, complementary and alternative medicine), neurofeedback and Cogmed. Adult ADHD cognitive behavioral therapy is described separately. These practice parameters summarize the evidence for psychosocial treatment. Based on this evidence, specific recommendations are provided for psychosocial interventions.

The Korean Practice Parameter for the Treatment of Pervasive Developmental Disorders : Pharmacological Treatment (전반적 발달장애의 한국형 치료 권고안 : 약물치료)

  • Cho, In-Hee;Yoo, Han-Ik K.;Son, Jung-Woo;Yoo, Hee-Jeong;Koo, Young-Jin;Chung, Un-Sun;Ahn, Dong-Hyun;Ahn, Joung-Sook
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.18 no.2
    • /
    • pp.109-116
    • /
    • 2007
  • The objective of this review is to establish practice parameters for pharmacological treatment of children and adolescents with pervasive developmental disorders. We performed a detailed review of the literature, including a wide range of controlled clinical trials, open trials, case reports, and side-effect profiles of related drugs. Few medications have a treatment indication for pervasive developmental disorders, and few studies with well-controlled methodology are available for evaluating treatment results. Pharmacological treatments focus on associated target symptoms because symptom reduction may improve educational and social ability and enhance quality of life. Well-controlled trials have been conducted for some SSRI(selective serotonin reuptake inhibitor) antidepressants, risperidone, and methylphenidate, and showed reduction of some target symptoms. Since the medications are not specific to autism and do not treat core symptoms of the disorder, their potential side effects should be carefully considered. Family education is necessary to give proper information on target symptoms, limitation of drug treatments, and risks.

  • PDF

The Korean Practice Parameter for the Treatment of Pervasive Developmental Disorders : Non-Pharmacological Treatment (전반적 발달장애의 한국형 치료 권고안 : 비약물적 치료)

  • Koo, Young-Jin;Cho, In-Hee;Yoo, Hee-Jeong;Yoo, Han-Ik K.;Son, Jung-Woo;Chung, Un-Sun;Ahn, Dong-Hyun;Ahn, Joung-Sook
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.18 no.2
    • /
    • pp.117-122
    • /
    • 2007
  • Practice parameters for non-pharmacological treatment of children and adolescents with pervasive developmental disorders are based on the scientific literature for evidence-based practices. Appropriate educational and behavioral interventions are important in improving the long-term outcome in pervasive developmental disorders. Early and sustained intervention appears to be particularly important. The goal for interventions is to gain pragmatic skills for verbal communication, playing with peers, daily living routines, self-management, and social adaptation. Appropriate involvement and collaboration with parents and family are essential for well-functioning intervention programs. The life-long nature of autism implies that the clinician should maintain an active role in long-term treatment planning and family support. Vocational training and training for more independent living are important for adolescents with autism. Professionals should be knowledgeable about local and national resources and opportunities for family support as well as support of the individual.

  • PDF

Evaluation of Photoneutron Dose in Radiotherapy Room Using MCNPX (MCNPX를 이용한 방사선 치료실의 광중성자 선량 평가)

  • Park, Eun-Tae
    • The Journal of the Korea Contents Association
    • /
    • v.15 no.6
    • /
    • pp.283-289
    • /
    • 2015
  • Recently, high energy photon radiotherapy is a growing trend for increasing therapy results. Commonly, if you use high energy photons above 6~8 MeV nominal accelerator voltage, It lead the photo-nuclear reaction and the generation of photo-neutron are accompanied and these problematic factors are issued in the view of radiation protection. Therefore, in this study analyzed for dose distribution of photo-neutron in radiotherapy room based on MCNPX. As a result, absorbed dose is increased sharply from 10 MV to 12 MV. It was founded that the rapid increasement of photoneutron fluence was related to the absorbed dose at above 10 MV. Also, in case of the recommendation of ICRP 103, the outcome of an exchanged equivalent dose which based on calculated an absorbed dose, showed lower equivalent dose than ICRP 60 by reflecting the contribution of secondary photon for absorbed dose of human body in the low energy band.

Effective and Safe Application of Radiofrequency Ablation for Benign Thyroid Nodules (양성갑상선결절에 대한 효과적이고 안전한 고주파절제의 적용)

  • Jin Yong Sung
    • Journal of the Korean Society of Radiology
    • /
    • v.84 no.5
    • /
    • pp.985-998
    • /
    • 2023
  • Radiofrequency ablation (RFA) has been a representative, non-surgical treatment for benign thyroid nodules that cause cosmetic problems or compression symptoms. The procedure of RFA should be performed effectively and safely. This review discusses the patient selection, pre-procedure evaluation and planning, principles, devices, techniques, and complications with reference to the guidelines and research on thyroid RFA. In particular, this review will devote to introduce RFA techniques and to provide practical help in the implementation of this procedure.

The Korean Practice Parameter for the Treatment of Pervasive Developmental Disorders : Diagnosis and Assessment (전반적 발달장애의 한국형 치료 권고안 : 진단 및 평가)

  • Yoo, Hee-Jeong;Cho, In-Hee;Koo, Young-Jin;Yoo, Han-Ik;Son, Jung-Woo;Chung, Un-Sun;Ahn, Joung-Sook;Ahn, Dong-Hyun
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.18 no.2
    • /
    • pp.97-108
    • /
    • 2007
  • Multiple areas of development are affected in pervasive developmental disorders(PDD), and assessments of various aspects of behavior and development are essential for diagnosis. The object of this review is to provide the practical guidelines for the assessment of core features of PDD, including abnormalities in communication, social interaction, and repetitive and stereotyped behavior. It covers the issues of differential diagnosis within and outside the PDD category, standardized diagnostic tools, assessment of intellectual and language functions, and the early diagnosis of PDD in infancy. This guideline also stresses the process of medical and neurological evaluation for proper diagnosis of PDD.

  • PDF

The Korean Practice Parameter for the Treatment of Pervasive Developmental Disorders : Development and Implications (전반적 발달장애의 한국형 치료 권고안 : 개발과정과 의의)

  • Ahn, Joung-Sook;Koo, Young-Jin;Son, Jung-Woo;Yoo, Han-Ik K.;Yoo, Hee-Jeong;Chung, Un-Sun;Cho, In-Hee;Ahn, Dong-Hyun
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.18 no.2
    • /
    • pp.85-87
    • /
    • 2007
  • The new research data and rapid development of psychotropic drugs over the past few years have warranted the development of clinical practice guidelines for managing pervasive developmental disorder(PDD). These guidelines are urgently needed due to the recent changes in social circumstances and clinical situations in Korea. Despite the many limitations and problems surrounding the development of these guidelines, the Korean Academy of Child and Adolescent Psychiatry(KACAP) has decided to develop the Korean Practice Parameters for the Treatment of PDD. The goal, basic principles, organization, and implications of this development project are introduced in this special paper. We expect these practice parameters to be a useful reference not only for child psychiatrists and other healthcare professionals in clinical practice, but also for the autistic patients themselves and their caregivers. The practice parameters shall be revised and improved in the near future.

  • PDF